Publications

Use of Both a Clinical Score and Rapid Antigen Test Improves the Bedside Diagnostic Accuracy to Detect Group A Streptococcus (GAS) Sore Throats. J. D. KELLNER1, P. AUFRICHT2, W. J. MCISAAC3, L. BUCHOLTZ2, A. VANJAKA4, D. E. LOW3; 1Univ. of Calgary, Calgary, AB, Canada, 2Crowfoot Village Fam. Prac., Calgary, AB, Canada, 3Mt. Sinai Hosp. & Univ. of Toronto, Toronto, ON, Canada, 4Abbott Laboratories, Montreal, PQ, Canada.

Background:
Treatment of GAS tonsillitis can be deferred pending throat culture results but there are often compelling reasons to decide on treatment at the initial clinical encounter. Our objectives were to further validate the McIsaac Sore Throat Score (MSTS) and evaluate the combined use of the MSTS and a rapid antigen test.

Methods:
Persons with acute sore throats presenting to a large family practice clinic in Calgary were screened with the MSTS and TestPack +Plus® ELISA rapid test. The MSTS has 4 items (temp >38º C, absence of cough, tender cervical nodes and tonsillar swelling or exudate) and an age modifier. A score of 0 to 4 is possible. The likelihood of GAS is <5% for scores of 0 and 1. For scores of 2, 3 & 4, the likelihood of GAS is 11%, 28% & 53%, respectively (CMAJ 1998;158:75). A throat culture for GAS was performed in all cases.

Results:
There were 757 patients with MSTS of >1 who were screened. A positive culture for GAS was found in 16%, 28% and 63% of those with MSTS of 2, 3 and 4, respectively.
Age
GAS Culture
Rapid Test Predictive Value
Positive
Negative
Sens
Spec
PV+
PV-
3 - 14 yrs
142 (40%)
213 (60%)
87%
99%
98%
92%
> 14 yrs
74 (19%)
328 (81%)
76%
99%
97%
95%
All ages
216 (29%)
538 (71%)
83%
99%
97%
94%

Sens = sensitivity, Spec = specificity, PV+ = positive predictive value, PV- = negative predictive value

Conclusions: 1) This study further validates the predictive value of the MSTS. 2) In patients with acute sore throat and a clinical score indicating intermediate or high likelihood of GAS (MSTS >1), performing a rapid test can accurately identify most true GAS cases at the initial visit and reduce the number of throat cultures required. This strategy would be useful in some settings.

 
Presented at:

42nd INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (ICAAC), San Diego, California, USA, September 27, 2002. 11:00am-12:30pm




©Copyright 2002 Last Modified